Award
NIH Reporter #5R01AI173780-04
Harnessing activated CD4 T cells to define new mechanisms of protection in tuberculosis
Recipient
Not specified
Award Amount
$590,248.00
Ceiling
$590,248.00
Awarded
June 10, 2026
Identifier
5R01AI173780-04
Research project funded by NIAID to study activated CD4 T cells in tuberculosis and develop immunotherapeutic strategies to enhance TB vaccines and treatments.
Description
This project aims to define the function of activated CD4 T cells in tuberculosis infection and test immunotherapeutic strategies targeting these cells, including OX40 agonist treatment, to improve TB vaccines and therapies.